SWHR Supports FDA Recommendations to Include Younger Women in Breast Cancer Research Posted on December 8, 2020 by Liz Hay - Resource
SWHR Comments to FDA on MDUFA Reauthorization for Fiscal Years 2023-2027 Posted on November 23, 2020 by Liz Hay - Resource
Position Statement: Inclusion of Sex as a Biological Variable in Research Posted on October 2, 2020 by Emily Ortman - Resource
SWHR Urges FDA OWH to Prioritize Inclusion of Pregnant Women in Clinical Trials Posted on September 9, 2020 by Liz Hay - Resource
SWHR Recommendations to FDA OWH on Strategic Priorities Posted on September 8, 2020 by Liz Hay - Resource
SWHR Recommendations to FDA for PDUFA Reauthorization for FY 2023-27 Posted on August 21, 2020 by Liz Hay - Resource
SWHR Feedback to NIH on Improving Biomedical Animal Research Posted on August 21, 2020 by Liz Hay - Resource
SWHR Feedback to Senate HELP Committee Chair on Pandemic Preparedness Plan Posted on June 23, 2020 by Liz Hay - Resource
SWHR Urges Inclusion of At-Risk Women in COVID-19 Research Posted on June 19, 2020 by Liz Hay - Resource